EMA Recommends Minimizing JAK Inhibitor Use for Some Patients

Older people, smokers and those with an increased risk of cardiovascular problems shouldn’t use Janus kinase inhibitors for chronic inflammatory diseases unless there are no other suitable treatment options, according to new recommendations by the European Medicines Agency (EMA).
Source: Drug Industry Daily